Aevolve

Aevolve was a private healthcare technology company focused on financing medical innovation through blockchain-based infrastructure rather than developing its own therapeutic pipeline. The company described itself as building a patient-centric healthcare marketplace and investment model intended to connect patients, innovators, and investors, with Biospheres positioned as its marketplace platform and AVEX as its tokenized ecosystem. Public descriptions emphasized support for drug, treatment, and medical technology development, including rare disease research, but there is no clear evidence that Aevolve itself advanced named therapeutic candidates into clinical development. Available business directories indicate the company was private and is now closed. For a biotech analyst, Aevolve is best understood as a health/biopharma financing platform adjacent to life sciences rather than a drug developer.